ABEONA THERAPEUTICS INC. - 10-Q Filing

Abeona Therapeutics filed a Form 10-Q for the quarter ended March 31, 2026. The filing includes financial data and disclosures related to customer concentration risk, accounts receivable by major customers, stock-based compensation activity, loan agreements, warrant liabilities, and fair value measurements of investments.

SEC EDGAR ·

Tickers: $ABEO

Read the full article at SEC EDGAR

More Regulatory news